CurveBeam AI Ltd. engages in the research, design, and manufacture of cone beam computed tomography imaging systems. The company is headquartered in Hatfield, Pennsylvania. The company went IPO on 2023-08-23. The Company’s orthopedic products include HiRise, LineUP, pedCAT Premium, pedCAT, InReach, and CubeVue Software. Its bone health products include InReach HR-pQCT, and OSSView. Its systems can be utilized across multiple locations via a mobile imaging solution that is self-contained and easy to operate. HiRise is a bilateral, weight bearing CT imaging of the entire lower extremities including hips/pelvis, distal upper extremities. LineUP is a bilateral, weight bearing CT imaging of the distal lower extremities and distal upper extremities. InReach HR-pQCT is a high resolution peripheral quantitative CT (HR-pQCT) imaging system designed for the point-of-care.
Follow-Up Questions
CRVAF の株価パフォーマンスは？
CRVAF の現在の価格は $0 で、最終取引日から 0% decreased 変動しました。
Curvebeam AI Ltd の主な事業テーマや業界は？
Curvebeam AI Ltd は Health Care 業界、セクターは Health Care に属しています。
